Work

Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study

Year: 2018

Type: article

Study design: Observational Study

Source: Journal of Oncology Pharmacy Practice

DOI: 10.1177/1078155218805539

Authors: Yuksel Urun, H Arzu Yasar, Hande Turna, Ece Esin, A Murat Sedef, Ali Alkan, Berna Oksuzoglu, Nuriye Ozdemir, MA Nahit Sendur, Ahmet Sezer, Saadettin Kılıckap, Gungor Utkan, Tulay Akman, Hakan Akbulut, Ismail Celik, Huseyin Abalı

Institutions: Ankara University, Istanbul University-Cerrahpaşa, Istanbul University, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Başkent University, Adana Hospital, Ministry of Health, Ankara Numune Eğitim ve Araştırma Hastanesi, Ankara Yıldırım Beyazıt University, Hacettepe University, Kent Hastanesi, Acıbadem University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2900104048

FWCI: 0.563

Cites: 27

Cited by: 10

Related to: 10